Beijing, China

Feifei Qi

This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignees: Beijing Immunochina Pharmaceuticals Co., Ltd., Beijing Yimiaoyiliao Co., Ltd. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Feifei Qi. Retrieved from https://idiyas.com/inventor/feifei-qi-6ukufqd1

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 50.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Feifei Qi: Innovator in Antibody Research

Introduction

Feifei Qi is a prominent inventor based in Beijing, China. He has made significant contributions to the field of antibody research, holding a total of 2 patents. His work focuses on innovative solutions that have the potential to impact medical science.

Latest Patents

Among his latest patents are "Antibody Specifically Binding to Strep-Tag II Tag and Use Thereof" and "Optimization of Chimeric Antigen Receptor." These patents reflect his dedication to advancing therapeutic techniques and improving patient outcomes.

Career Highlights

Feifei Qi has worked with notable companies such as Beijing Immunochina Pharmaceuticals Co., Ltd. and Beijing Yimiaoyiliao Co., Ltd. His experience in these organizations has allowed him to apply his research in practical settings, contributing to the development of new medical technologies.

Collaborations

Feifei has collaborated with talented individuals in his field, including Ting He and Xinan Lu. Their combined expertise has fostered an environment of innovation and discovery.

Conclusion

Feifei Qi's contributions to antibody research and his innovative patents highlight his role as a key figure in the scientific community. His work continues to inspire advancements in medical technology and therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…